Table 3.
Factors (in favor of) | p |
---|---|
Primary site (lung) |
0.01 |
Pretreatment KPS (≥60) |
0.03 |
Interval between two courses of WBRT (≥9.5 months) |
0.01 |
SRS (application) |
0.57 |
Extracranial metastasis (in control) |
0.86 |
Number of metastasis in the brain (<5) |
0.48 |
BEDcumulative (≥129.5 Gy) | 0.62 |
KPS Karnofsky performance scale, WBRT whole brain radiotherapy, SRS stereotactic radiosurgery, BED biological effective dose.